arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

60 DEGREES PHARMACEUTICALS, INC.

SXTP

$1.14 ▲ +0.10 (+9.62%) at close

19 Visible periods

30 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Moderately Bearish

auto_awesome

Analytical Summary

60 DEGREES PHARMACEUTICALS, INC. faces fundamental challenges with weakness in Return on Common Equity (%). Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $3.0M

Dividend Yield —

Revenue Growth 106.0% ↗

Op. Margin None

ROIC -64.9% ↘

FCF / Share $-0.84 ↗

Trailing P/E —

Price / Book 1.2x

FCF Yield —

Debt / Equity 0.06

info Valuation on last close. End-of-day price, Sep 23, 2026.

19-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$207.90K

↑ +106.0% —

Net Income Profit after all expenses

$-2.26M

↓ -30.6% —

FCF / Share Free cash flow per share

$-0.84

↑ +47.6% —

Long-Term Debt Long-term obligations

$150.03K

— 0.0% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns

Financial Health →

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Nov 4, 2022 10-Q ↗	Q2 FY2022 Nov 4, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Mar 31, 2022 10-K ↗
Revenue Growth YoY (%)	106.0% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1225%)	-0.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-111%)	25.6% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+219%)	223.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2693%)	-19.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-340%)	40.4% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+405%)	92.3% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1053%)	164.3% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1954%)	109.9% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1274%)	578.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+7128%)	N/M	-69.6% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-970%)	31.8% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+297%)	—	—	—	—	—	—
EPS Growth YoY (%)	28.0% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	17.9% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	83.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	29.0% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	70.4% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	0.3% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	N/M	-202.1% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	-7521.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	-45.8% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—
Net Income Growth YoY (%)	-30.6% Weak ↓ Weak Declining Year-over-year change in net income	-11.3% Weak ↓ Weak Declining Year-over-year change in net income	29.7% Excellent ↑ Excellent Improving Year-over-year change in net income	-7.2% Weak ↓ Weak Declining Year-over-year change in net income	58.5% Excellent Excellent Year-over-year change in net income	N/M	-1.6% Weak Weak Year-over-year change in net income	N/M	-25.1% Weak Weak Year-over-year change in net income	N/M	-20.1% Weak Weak Year-over-year change in net income	N/M	-55.4% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	—	-28.8% Weak Weak Year-over-year change in free cash flow	—	—	—	-1006.8% Weak Weak Year-over-year change in free cash flow	—	—	—	37.1% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	51.7% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	111.3% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	—	37.5% Excellent Excellent Compound annual revenue growth over 3 years	30.7% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Nov 4, 2022 10-Q ↗	Q2 FY2022 Nov 4, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Mar 31, 2022 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-127.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-953%)	—	—	—
Effective Tax Rate (%) (%)	—	—	0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—
Profit Margin (%) (%)	—	—	-474.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4051%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	—	—	-484.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	-95.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	177.5% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	-182.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—
FCF / Net Income (x)	0.99x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.33x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.23x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.85x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	-2.65x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.06x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.16x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.04x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.21x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Nov 4, 2022 10-Q ↗	Q2 FY2022 Nov 4, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Mar 31, 2022 10-K ↗
Return on Invested Capital (%)	-64.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-33.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-53.0% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-50.8% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-62.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-44.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-49.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-34.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-131.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-18.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-38.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-1014.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	3.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	2.9% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—
Return on Capital (%) (%)	-53.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-31.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-35.7% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-34.8% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-38.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-32.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-35.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-28.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-96.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-15.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-24.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-52.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-86.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-677%)	-43.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-388%)	-41.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-377%)	-52.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-449%)	-71.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-576%)	-45.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-404%)	-50.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-438%)	-35.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-338%)	-137.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1016%)	6.0% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-60%)	-41.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-375%)	—	15.0% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	—	7.1% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-53%)	—	—	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Nov 4, 2022 10-Q ↗	Q2 FY2022 Nov 4, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Mar 31, 2022 10-K ↗
Debt to Equity (x)	0.06x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-90%)	0.03x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-95%)	0.04x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-93%)	0.03x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-94%)	0.06x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-90%)	0.04x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-94%)	0.04x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-94%)	0.02x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-96%)	0.05x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-92%)	0.02x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-97%)	—	—	-0.01x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-101%)	—	—	—	—	—	—
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	-949.83x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-37.94x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-0.72x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-0.83x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-0.62x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-0.18x Weak Weak Operating income divided by interest expense Optimal: > 5x	-0.76x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$-872.58K	$-3.19M	$-1.36M	$-3.97M	$-1.82M	$-3.30M	$-1.51M	$-3.15M	$-1.43M	$150.00K	$-2.14M	$150.00K	$150.00K	—	—	—	—	—	—
Debt / EBITDA (x)	-0.07x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.07x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.08x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.06x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.09x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.08x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.07x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.07x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.04x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.11x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-0.10x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.19x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Nov 4, 2022 10-Q ↗	Q2 FY2022 Nov 4, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Mar 31, 2022 10-K ↗
Revenue per Share (USD)	$0.08	$0.09	—	$0.12	$0.07	$0.13	—	$0.06	$0.12	$0.01	—	$0.01	$0.03	$0.01	—	$0.07	$0.02	—	—
Basic EPS, GAAP (USD)	$-0.90	$-1.28	$-8.81	$-0.66	$-1.25	$-1.56	$-52.43	$-0.93	$-4.23	$0.03	$-52.59	$0.77	$-1.40	$-1.13	$-0.69	$-0.61	$-0.96	—	—
Free Cash Flow per Share (USD)	$-0.84	$-1.61	—	$-0.58	—	$-1.25	—	—	—	$-0.11	—	—	—	$-0.18	—	$-0.13	—	—	—
Book Value per Share (USD)	$0.98	$0.89	$2.98	$1.08	$1.65	$2.79	$0.19	$3.24	$2.98	$0.61	—	—	$-9.38	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$0.87	$0.84	$2.78	$1.04	$1.55	$2.69	$0.18	$3.10	$2.74	$0.59	—	—	$-9.46	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	2.65M	1.73M	—	3.68M	1.47M	1.28M	—	2.44M	1.01M	10.12M	—	5.32M	2.38M	2.30M	—	2.39M	2.35M	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Nov 4, 2022 10-Q ↗	Q2 FY2022 Nov 4, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Mar 31, 2022 10-K ↗
Working Capital (USD)	$2.13M	$4.38M	$3.05M	$4.11M	$2.15M	$3.85M	$3.73M	$5.58M	$2.54M	$6.80M	$4.41M	$6.41M	$-23.19M	—	$-22.82M	—	—	—	—
LT Debt (USD)	$150.03K	$150.03K	$150.00K	$150.00K	$150.00K	$150.00K	$147.12K	$150.00K	$150.00K	$150.00K	—	$150.00K	$150.00K	—	—	—	—	—	—
Total Equity (USD)	$2.61M	$4.83M	$3.46M	$4.43M	$2.43M	$4.11M	$4.04M	$6.04M	$3.04M	$7.20M	$4.87M	—	$-22.30M	—	$-23.58M	—	—	—	—

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Nov 4, 2022 10-Q ↗	Q2 FY2022 Nov 4, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Mar 31, 2022 10-K ↗
Sales/Revenue/Turnover (USD)	$207.90K	$162.09K	$303.38K	$437.60K	$100.93K	$163.55K	$241.63K	$135.29K	$124.97K	$116.46K	$125.68K	$51.19K	$59.53K	$17.17K	$-37.17K	$168.19K	$45.17K	—	—
Depreciation Expense (USD)	$16.95K	$16.70K	$15.17K	$12.22K	$9.24K	$6.69K	$5.45K	$4.33K	$1.54K	$407.00	$1.88K	$5.49K	$6.90K	$6.90K	$6.90K	$6.90K	$6.90K	—	—
Net Income, GAAP (USD)	$-2.26M	$-2.09M	$-1.44M	$-2.32M	$-1.73M	$-1.88M	$-2.05M	$-2.16M	$-4.17M	$430.47K	$-2.01M	$4.18M	$-3.34M	$-2.60M	$-1.68M	$-1.45M	$-2.15M	—	—
Operating Cash Flow (USD)	$-2.23M	$-2.74M	$-1.69M	$-2.11M	—	$-1.60M	$-1.64M	—	—	$-1.14M	$-63.67K	—	—	$-412.68K	$-65.98K	$-307.06K	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 5 years · 19 quarters

60 DEGREES PHARMACEUTICALS, INC.

Analytical Summary

19-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare SXTP with peers